Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044
NCT01419470
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Premature Ejaculation
Interventions
DRUG:
dapoxetine
Sponsor
Yuhan Corporation